15683382

Chekir C

2005

Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome.

15687346

Piaditis G

2005

Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries.

15689292

Andy C

2005

Clinical inquiries. Do insulin-sensitizing drugs increase ovulation rates for women with PCOS?

15690321

Musso C

2005

The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.

15690710

Owecki M

2004

[Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].

15690755

Jackson ML

2004

Polycystic ovarian syndrome: what nurses need to know about this misunderstood disorder.

15693477

Rachdi R

2004

[Surgical laparoscopy in the management of women infertility].

15693578

Jones AE

2005

Diagnosis and treatment of polycystic ovarian syndrome.

15695109

Sepilian V

2005

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.

15695312

S?derstr?m-Anttila V

2005

Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients.

15695318

S?derlund D

2005

No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.

15697072

Sahin I

2004

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.

15697073

Berker B

2004

Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.

15697074

Weerakiet S

2004

Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome.

15697105

Villaseca P

2004

Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.

15700636

Miggiano GA

2004

[Endocrine obesity: bioelectric profiles (biotypes) detected in the body composition].

15705302

Kumari AS

2005

Metformin monotherapy in lean women with polycystic ovary syndrome.

15705366

Barbieri RL

2005

Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization.

15705376

Rizk AY

2005

N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome.

15705377

Witchel SF

2005

Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.

15705403

Schwimmer JB

2005

Abnormal aminotransferase activity in women with polycystic ovary syndrome.

15705414

Glass KB

2005

Diagnosing insulin resistance--a clarification.

15705619

Hwang JL

2005

IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial.

15705622

Tok EC

2005

Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype.

15705917

Powell BL

2005

Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits.

15710314

Aykutlu E

2005

Add-on therapy with topiramate in progressive myoclonic epilepsy.

15713728

Legro RS

2005

Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.

15717440

Tulandi T

1996

Modern surgical approaches to female reproductive tract.

15717649

Sieminska L

2004

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.

15720866

Bhathena RK

2005

Drospirenone and PCOS.

15722615

van Weissenbruch MM

2005

Fetal nutrition and timing of puberty.

15722616

Ong K

2005

Adrenal function of low-birthweight children.

15722622

Homburg R

2005

Polycystic ovary syndrome in adolescence. New insights in pathophysiology and treatment.

15722670

Iyengar S

2005

Difficult cases in heart failure: polycystic ovary syndrome and heart failure.

15724800

Dale PO

2004

The impact of insulin resistance on the outcome of laparoscopic ovarian electrocautery in infertile women with the polycystic ovary syndrome.

15724802

Karabacak IY

2004

Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease.

15724803

Weerakiet S

2004

Efficacy of metformin on ovulation induction in Asian women with polycystic ovary syndrome.

15724804

Nasiek M

2004

Plasma concentration of soluble intercellular adhesion molecule-1 in women with polycystic ovary syndrome.

15726910

Nardo LG

2004

Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate.

15728200

Chhabra S

2005

Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.

15728203

Carmina E

2005

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters.

15730359

Lowe P

2005

Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia.

15730409

Cussons AJ

2005

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.

15730543

Fl?ck CE

2005

Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase/17,20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2.

15731326

Mozzanega B

2004

Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome.

15733404

Wu XK

2004

[Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome].

15733735

Arner P

2005

Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome.

15733898

Shen ZJ

2005

Inhibin B, activin A, and follistatin and the pathogenesis of polycystic ovary syndrome.

15734089

Api M

2005

Laparoscopic ovarian drilling in polycystic ovary syndrome.

15734091

Tolino A

2005

Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.

15734758

Bokal EV

2005

Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome.

15738027

Soliman PT

2005

Risk factors for young premenopausal women with endometrial cancer.

15741256

Vryonidou A

2005

Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.

15742970

Liu HK

2005

Changes in egg production rate induced by progesterone injection in broiler breeder hens.

15745643

Dumesic DA

2005

Early origins of polycystic ovary syndrome.

15745936

Rautio K

2005

Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.

15746649

Glueck CJ

2005

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia.

15748930

Adams Hillard PJ

2005

Menstrual disorders in the college age female.

15749068

Porter TF

2005

Evidence-based care of recurrent miscarriage.

15752674

Dewailly D

2005

[Response of D. Dewailly to the article by S. Trim?che et al].

15754469

Hammerschmidt DE

2005

Polycystic ovaries.

15755044

Bah?eci M

2005

Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.

15755857

Gennarelli G

2005

Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome.

15757855

Carmina E

2005

Evidence for altered adipocyte function in polycystic ovary syndrome.

15758867

Pasquali R

2005

Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome.

15760320

Meyer C

2005

Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome.

15760780

Rizvi AA

2004

Some clues and pitfalls in the diagnosis of acromegaly.

15762040

Diamanti-Kandarakis E

2004

Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance.

15765620

Bayram F

2002

Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome.

15767238

Stout DL

2005

Thiazolidinediones for treatment of polycystic ovary syndrome.

15771636

Malkawi HY

2005

Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome?

15772904

Kamel N

2005

Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.

15774212

Lu XP

2005

[Expression of leptin mRNA in luteinized granulosa cells and leptin levels in serum and follicular fluid of non-obese infertile patients with polycystic ovary syndrome].

15775883

Tekin O

2004

Hirsutism: common clinical problem or index of serious disease?

15778926

Spritzer PM

2005

Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.

15780012

Trent M

2005

Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life.

15780534

Margolin E

2005

Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome.

15782458

Cooper HE

1968

Hereditary factors in the Stein-Leventhal syndrome.

15786646

Rouiller DG

2005

[Hirsutism].

15787604

Farese RV

2005

Atypical protein kinase C in insulin action and insulin resistance.

15788499

Ehrmann DA

2005

Polycystic ovary syndrome.

15790014

Theintz G

2005

[From obesity to type 2 diabetes in children and adolescents].

15790599

Vrb?kov? J

2005

Combined oral contraceptives in the treatment of polycystic ovary syndrome.

15790610

Kilicdag EB

2005

Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial.

15791860

Wang Y

2004

Expression of resistin mRNA in adipose tissue of rat model with polycystic ovarian syndrome and its implication.

15791913

Castro-Acu?a V

2004

[Insulin resistance inpolycystic ovary syndrome].

15793791

Tan L

2005

[Relationship between the microsatellite polymorphism of CYP11 alpha gene and the pathogenesis of hyperandrogenism of polycystic ovary syndrome in Chinese].

15795180

Manni L

2005

Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries.

15797965

Legro RS

2005

Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

15798585

Lorcy Y

2005

[Micropolycystic ovaries and insulin-resistance syndrome].

15799658

Costello MF

2005

Polycystic ovary syndrome--a management update.

15802312

Sir-Petermann T

2005

Birth weight in offspring of mothers with polycystic ovarian syndrome.

15802316

Ib??ez L

2005

Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.

15802318

Petry CJ

2005

Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.

15802320

Eldar-Geva T

2005

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.

15802325

Piltonen T

2005

Serum anti-M?llerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

15808380

Altuntas Y

2005

Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function.

15811215

Filippatos TD

2005

A review of the metabolic effects of sibutramine.

15816371

Zulian E

2005

Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

15816376

Angelopoulos N

2005

The role of luteinizing hormone activity in controlled ovarian stimulation.